Searching for a cure for frailty

15 Nov 2016

An in-depth analysis of blood cells reveals signs of aging

A*STAR researchers are looking for biological markers of physical frailty.

A*STAR researchers are looking for biological markers of physical frailty.


According to Anis Larbi, who is trying to revolutionize the way elderly people are cared for, “doctors can’t give you drugs just because you complain of being old.” Larbi and his team at the A*STAR Singapore Immunology Network (SIgN) are looking at aging as a complex process, including the appearance of symptoms as with disease, the first of which is frailty.

Along with collaborators in Singapore, China and Canada, Larbi’s team is the first to identify a link between inflammation, immunity and the signs of physical frailty. “By determining the biological signature of frailty, we can start thinking of possible medical interventions.”

Frailty is a condition associated with aging that limits a person’s mobility and increases their risk of falling, hospitalization and death. “Frailty per se will not kill you,” says Larbi. “But it will affect your quality of life.” Unlike most diseases for which there are underlying causes, scientists have typically described frailty in purely symptomatic terms. Larbi and his co-workers wanted to understand whether an ‘immunological frailty’ is also present in the general state of malaise.

The researchers recruited around 100 Singaporean adults aged 55 or older from the Singapore Longitudinal Aging Study. They were assessed for their level of frailty based on two established models — the Fried frailty status, which looks at five physical symptoms from slowness to weight loss, and the Rockwood Frailty Index, which measures a broader range of dysfunctions. Blood samples were analyzed for markers of inflammation and signs of aging in immune cells.

Of the multiple biomarkers simultaneously tested using multiplex technology at the Immunomonitoring Platform at SIgN, eight were found to be either positively or negatively associated with frailty. Two of the biomarkers are linked to interleukin-6, an inflammatory cytokine which is associated with many age-related diseases.

At the cellular level, frailer people had higher levels of two types of white blood cells — poorly functioning, exhausted B cells, and inflammatory CD14+CD16monocytes. Cytotoxic T cells in these individuals “looked older”, expressing lower levels of a protein called CD28, which is essential for their activation, proliferation, differentiation and overall survival.

The researchers are conducting similar analyses on elderly populations in other regions. “We want to know if these indicators are specific to Asia, or if there is a universal signature for frailty,” says Larbi. Further molecular studies could ultimately lead to methods for detecting frailty early in life and identifying pathways to slow down debilitating physical symptoms.

The A*STAR-affiliated researchers contributing to this research are from the Singapore Immunology Network.

Want to stay up-to-date with A*STAR’s breakthroughs? Follow us on Twitter and LinkedIn!


Lu, Y., Tan, C. T. Y., Nyunt, M. S. Z., Mok, E. W. H., Camous, X. et al. Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studies. Oncotarget 7, 28783–28795 (2016). | Article

This article was made for A*STAR Research by Nature Research Custom Media, part of Springer Nature